Loading clinical trials...
Loading clinical trials...
The classic Ph-negative myeloproliferative neoplasms (MPN) are a group of clonal hematopoietic disorders caused by a dysregulated JAK/STAT signal transduction because of acquired somatic mutations of ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
NCT07204392 · Myeloproliferative Disease, Germline Mutation
NCT06727383 · Healthy Donors, Myeloproliferative Diseases, and more
NCT05553873 · Myeloproliferative Disease, Inflammatory Markers
NCT03434730 · Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, and more
NCT07569523 · Preterm Infant Development, COVID - 19
Fondazione IRCCS Policlinico San Matteo
Pavia, Lombardy
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions